Mechanism of Action of Terbinafine

Introduction

Terbinafine is an allylamine antifungal agent used for the treatment of dermatophyte infections such as tinea pedis, tinea corporis, tinea cruris, and onychomycosis. It exerts a fungicidal effect by inhibiting ergosterol synthesis in fungal cell membranes. The drug is particularly effective against dermatophytes and is one of the most commonly prescribed oral antifungal medications for nail infections.


Mechanism of Action (Step-wise)

  1. Fungal cell membranes require ergosterol for structural integrity and normal cellular function.
  2. Ergosterol synthesis occurs through a multistep biochemical pathway.
  3. One of the early steps involves conversion of squalene into squalene epoxide.
  4. This reaction is catalyzed by the enzyme squalene epoxidase.
  5. Terbinafine selectively inhibits fungal squalene epoxidase.
  6. Inhibition of this enzyme blocks ergosterol synthesis.
  7. Ergosterol concentration within the fungal cell membrane decreases.
  8. Cell membrane structure and function become impaired.
  9. Simultaneously, intracellular squalene accumulates.
  10. Excess squalene becomes toxic to fungal cells.
  11. Membrane permeability and cellular metabolism are disrupted.
  12. Fungal cell death occurs, producing a fungicidal effect against dermatophytes.
  13. The overall effect is eradication of susceptible fungal infections.

A key exam point is that terbinafine inhibits squalene epoxidase, causing ergosterol depletion and toxic accumulation of squalene in fungal cells.

Mechanism of action of Terbinafine
MOA of Terbinafine
Mechanism of Action of Terbinafine Flowchart
Flowchart of mechanism of action of Terbinafine

Pharmacokinetics

Terbinafine can be administered orally or topically. Oral terbinafine is well absorbed and extensively distributed into skin, hair, and nails. It undergoes hepatic metabolism and is eliminated primarily through urine. Because of its accumulation in keratinized tissues, therapeutic effects persist even after treatment cessation.


Clinical Uses

Terbinafine is used in:

  • Onychomycosis
  • Tinea pedis (athlete’s foot)
  • Tinea corporis
  • Tinea cruris
  • Tinea capitis
  • Dermatophyte infections

Adverse Effects

Common adverse effects include:

  • Headache
  • Nausea
  • Diarrhea
  • Abdominal discomfort
  • Rash

Serious adverse effects may include:

  • Hepatotoxicity
  • Severe skin reactions
  • Taste disturbances
  • Rare neutropenia

Liver function monitoring may be recommended during prolonged oral therapy.


Comparative Analysis

FeatureTerbinafineFluconazoleKetoconazole
Drug classAllylamineAzoleAzole
Main targetSqualene epoxidase14-α demethylase14-α demethylase
Ergosterol synthesis inhibitionYesYesYes
Squalene accumulationYesNoNo
Activity against dermatophytesExcellentModerateModerate
Onychomycosis treatmentFirst-lineAlternativeRarely used

Terbinafine differs from azole antifungals because it inhibits squalene epoxidase rather than fungal cytochrome P450-dependent 14-α demethylase. This leads to toxic accumulation of squalene in fungal cells and a fungicidal effect.


MCQs

1. Terbinafine belongs to which antifungal class?

a) Azoles
b) Polyenes
c) Allylamines
d) Echinocandins

Answer: c) Allylamines

2. Terbinafine inhibits:

a) β-glucan synthase
b) Squalene epoxidase
c) DNA gyrase
d) Chitin synthase

Answer: b) Squalene epoxidase

3. Squalene epoxidase is involved in synthesis of:

a) Ergosterol
b) Cholesterol
c) Histamine
d) Peptidoglycan

Answer: a) Ergosterol

4. Terbinafine causes accumulation of:

a) Ergosterol
b) Squalene
c) Cholesterol
d) Acetylcholine

Answer: b) Squalene

5. Ergosterol is an important component of:

a) Bacterial cell walls
b) Fungal cell membranes
c) Human red blood cells
d) Viral envelopes

Answer: b) Fungal cell membranes

6. Terbinafine is commonly used for:

a) Onychomycosis
b) Malaria
c) Tuberculosis
d) Influenza

Answer: a) Onychomycosis

7. The effect of terbinafine against dermatophytes is generally:

a) Fungistatic
b) Fungicidal
c) Bactericidal
d) Virucidal

Answer: b) Fungicidal

8. A common adverse effect is:

a) Headache
b) Hypercalcemia
c) Bradycardia
d) Cataracts

Answer: a) Headache

9. A serious adverse effect is:

a) Hepatotoxicity
b) Hypernatremia
c) Polycythemia
d) Hyperthyroidism

Answer: a) Hepatotoxicity

10. Terbinafine accumulates particularly in:

a) Bone marrow
b) Keratinized tissues
c) Cerebrospinal fluid
d) Skeletal muscle

Answer: b) Keratinized tissues

11. Compared with azoles, terbinafine targets:

a) 14-α demethylase
b) Squalene epoxidase
c) DNA polymerase
d) β-tubulin

Answer: b) Squalene epoxidase

12. The antifungal activity of terbinafine results mainly from:

a) Ergosterol depletion and squalene accumulation
b) Cell wall synthesis stimulation
c) Protein synthesis inhibition
d) DNA replication enhancement

Answer: a) Ergosterol depletion and squalene accumulation


FAQs

What is the mechanism of action of terbinafine?

Terbinafine inhibits squalene epoxidase, leading to decreased ergosterol synthesis and toxic accumulation of squalene in fungal cells.

Why is terbinafine effective against dermatophytes?

It produces a fungicidal effect by disrupting fungal cell membrane integrity and causing fungal cell death.

What is the primary target enzyme of terbinafine?

Squalene epoxidase.

What are common side effects of terbinafine?

Headache, nausea, diarrhea, abdominal discomfort, and rash.

Why is terbinafine commonly used for onychomycosis?

Because it accumulates in nails and remains effective against dermatophytes for prolonged periods.

How does terbinafine differ from azole antifungals?

Terbinafine inhibits squalene epoxidase, whereas azoles inhibit fungal 14-α demethylase.


References

Goodman & Gilman’s The Pharmacological Basis of Therapeutics
https://accessmedicine.mhmedical.com/book.aspx?bookid=3191

Katzung’s Basic and Clinical Pharmacology
https://accessmedicine.mhmedical.com/content.aspx?bookid=3382

Tripathi KD. Essentials of Medical Pharmacology
https://www.jaypeedigital.com

Harrison’s Principles of Internal Medicine
https://accessmedicine.mhmedical.com

Author

  • Harsh Singh Author Pharmacy Freak

    Harsh Singh Rajput is a pharmacist currently working at ESIC and holds an MBA in Pharmaceutical Management from NIPER Hyderabad. He has a strong academic record with top ranks in national-level pharmacy exams, including AIR 61 in NIPER 2024 (MS/M.Pharm), AIR 27 in NIPER MBA, AIR 147 in GPAT 2024, AIR 907 in GPAT 2023, and AIR 6 in AIIMS CRE-2025 for Drug Store Keeper. At PharmacyFreak.com, he contributes expert content, exam strategies, and practical guidance for future pharmacists.
    Mail- harsh@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators